ArticleMicroorganisms2026
An Exploratory Evaluation of the Present Prevalence of Hepatitis D Infection in Selected Populations from Venezuela, Contrasted with Past Studies in the Country.
Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
Hepatitis D virus (HDV) is a satellite virus that requires the presence of a helper virus, the hepatitis B virus (HBV). Soon after its discovery by Mario Rizzetto in 1977, severe outbreaks of fulminant hepatitis D occurred in the past century, in indigenous populations from the Western and Southern (Amazon) regions of Venezuela, while the indigenous population from the Eastern region (Orinoco Delta) has been found to be free of this virus. Data on the prevalence of HDV infection in Venezuela are still highly imprecise. The aim of this study is to provide insights into the current situation of this disease in the country. Evidence of exposure and infection with HDV was found again mainly in indigenous populations, although also one patient with hepatitis B from the capital was found to be infected with HDV genotype 1. The genotype found in the indigenous Bari population was HDV genotype 1, the same lineage (a putative new subgenotype 1j) previously identified in this region in both Venezuela and Colombia. Although scarce information is still available about the burden of HDV infection in Venezuela, the few studies available are consistent in showing an epidemic concentrated mainly in some, but not all, indigenous populations. Reflex testing is needed to have a better appraisal of this disease in the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.